logo
episode-header-image
May 2021
41m 54s

Using AI to Map the Human Immune System ...

Sam Charrington
About this episode

Today we’re joined by Jabran Zahid, a Senior Researcher at Microsoft Research.

In our conversation with Jabran, we explore their recent endeavor into the complete mapping of which T-cells bind to which antigens through the Antigen Map Project. We discuss how Jabran’s background in astrophysics and cosmology has translated to his current work in immunology and biology, the origins of the antigen map, the biological and how the focus was changed by the emergence of the coronavirus pandemic.

We talk through the biological advancements, and the challenges of using machine learning in this setting, some of the more advanced ML techniques that they’ve tried that have not panned out (as of yet), the path forward for the antigen map to make a broader impact, and much more.

The complete show notes for this episode can be found at twimlai.com/go/485.

Up next
Aug 19
Genie 3: A New Frontier for World Models with Jack Parker-Holder and Shlomi Fruchter - #743
Today, we're joined by Jack Parker-Holder and Shlomi Fruchter, researchers at Google DeepMind, to discuss the recent release of Genie 3, a model capable of generating “playable” virtual worlds. We dig into the evolution of the Genie project and review the current model’s scaled-u ... Show More
1h 1m
Aug 12
Closing the Loop Between AI Training and Inference with Lin Qiao - #742
In this episode, we're joined by Lin Qiao, CEO and co-founder of Fireworks AI. Drawing on key lessons from her time building PyTorch, Lin shares her perspective on the modern generative AI development lifecycle. She explains why aligning training and inference systems is essentia ... Show More
1h 1m
Jul 29
Context Engineering for Productive AI Agents with Filip Kozera - #741
In this episode, Filip Kozera, founder and CEO of Wordware, explains his approach to building agentic workflows where natural language serves as the new programming interface. Filip breaks down the architecture of these "background agents," explaining how they use a reflection lo ... Show More
46m 1s
Recommended Episodes
Nov 2022
Epigenetics in Human Malaria Parasites (Elena Gómez-Diaz)
In this episode of the Epigenetics Podcast, we caught up with Elena Gomez-Diaz from the Institute of Parasitology and Biomedicine López-Neyra at the Spanish National Research Council. She share with us her work on the Epigenetics in Human Malaria Parasites. Elena Gómez-Díaz and h ... Show More
37m 22s
Mar 2023
How to build a virus-proof cell
00:47 An edited genetic code that prevents viral infectionResearchers have engineered bacteria with synthetic genomes to be immune to viral infection. The team streamlined the bacteria’s genetic code, and re-engineered the protein-producing machinery to insert the wrong amino aci ... Show More
31m 38s
Dec 2019
New malaria target
Molecular scale investigations have identified the mechanism which confers resistance to antimalarial drugs. Researchers hope work to turn off this mechanism could mean cheaper well known antimalarials can become effective once again. We look at the threat to weather forecasting ... Show More
29m 18s
Oct 2021
Drug resistant malaria found in East Africa
Since their discovery in the 1970s, artemisinin-based drugs have become the mainstay of treatment for malaria caused by the Plasmodium falciparum parasite. Researchers have identified artemisinin-resistant malaria parasites in Southeast Asia since the early 2000s, but now, there ... Show More
1h 1m
Jul 2022
Immunai CTO and Co-Founder Luis Voloch on Using Deep Learning to Develop New Drugs - Ep. 176
What if we could map our immune system to create drugs that can help our bodies win the fight against cancer and other diseases? That’s the big idea behind immunotherapy. The problem: the immune system is incredibly complex. Enter Immunai, a biotechnology company that’s using AI ... Show More
27m 52s
May 2021
Man, Mosquito, Malaria Vaccine
Playing out against the backdrop of a global pandemic (including recent massive surges in regions around the world) is the news that came out a week ago that a candidate "malaria vaccine becomes first to achieve WHO-specified 75% efficacy goal”. While the findings are still in pr ... Show More
36m 20s
Jul 2020
What We Know About Immunity
In the race to study immunity to the virus, scientists first focused on antibodies -- proteins that stick to and disable foreign invaders. That’s because creating antibodies is the basis for most successful vaccines, so scientists are interested in learning who develops coronavir ... Show More
10m 59s
Nov 2021
Malaria: what's in it for the mosquito?
Malaria, a disease that infects hundreds of millions of people and kills hundreds of thousands each year. It is caused after a plasmodium parasite is passed from a blood-feeding mosquito into a human host. Subject to much research over hundreds of years, of both host and parasite ... Show More
36m 11s
Jul 2021
A life-changing database
Proteomes, the sequences of protein within the DNA of every living thing, are notoriously difficult to model. The usual chemical methods can take months, but a new computational model using the ability of artificial intelligence to learn the complex sequences is able to predict s ... Show More
32m 51s
Sep 2021
Uncontrolled Spread: Science, Policy, Institutions, Infrastructure
There's no question technology played a huge role in the recent/current pandemic, including especially in the plug-and-play engineering and incredibly fast development behind the mRNA vaccines... But is there an even bigger role for the private sector, not just government, to pla ... Show More
56m 17s